Cryptogenic stroke and patent foramen ovale

MK Mojadidi, MO Zaman, IY Elgendy… - Journal of the American …, 2018 - jacc.org
Nearly one-half of patients with cryptogenic stroke have a patent foramen ovale (PFO). The
dilemma of whether to close these PFOs percutaneously, in an effort to reduce the risk of …

Percutaneous closure versus medical treatment in stroke patients with patent foramen ovale: a systematic review and meta-analysis

S De Rosa, H Sievert, J Sabatino… - Annals of internal …, 2018 - acpjournals.org
Background: New evidence emerged recently regarding the percutaneous closure of patent
foramen ovale (PFO) to prevent recurrent stroke in patients with cryptogenic stroke. Purpose …

Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects

AN Mahmoud, A Mentias, AY Elgendy, A Qazi… - BMJ open, 2018 - bmjopen.bmj.com
Objectives To perform an updated meta-analysis to evaluate the long-term cardiovascular
and cerebrovascular outcomes among migraineurs. Setting A meta-analysis of cohort …

Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials

Y Ahmad, JP Howard, A Arnold, MS Shin… - European heart …, 2018 - academic.oup.com
Aims The efficacy of patent foramen ovale (PFO) closure for cryptogenic stroke has been
controversial. We undertook a meta-analysis of randomized controlled trials (RCTs) …

SCAI expert consensus statement on operator and institutional requirements for PFO closure for secondary prevention of paradoxical embolic stroke: The American …

E Horlick, CJ Kavinsky, Z Amin… - Catheterization and …, 2019 - Wiley Online Library
Until recently, evidence to support Patent Foramen Ovale (PFO) closure for secondary
prevention of recurrent stroke has been controversial. Publication of high‐quality evidence …

Patent foramen ovale closure, antiplatelet therapy or anticoagulation in patients with patent foramen ovale and cryptogenic stroke: a systematic review and network …

H Mir, RAC Siemieniuk, LC Ge, F Foroutan, M Fralick… - BMJ open, 2018 - bmjopen.bmj.com
Objective To examine the relative impact of three management options in patients aged< 60
years with cryptogenic stroke and a patent foramen ovale (PFO): PFO closure plus …

Patent foramen ovale and hypoxemia

MK Mojadidi, JC Ruiz, J Chertoff, MO Zaman… - Cardiology in …, 2019 - journals.lww.com
Patent foramen ovale (PFO), an embryonic remnant of the fetal circulation, is present in 20–
25% of adults. Although recent observational studies and clinical trials have established the …

Uncertainties and controversies in the management of ischemic stroke and transient ischemic attack patients with patent foramen ovale

SE Kasner, S Lattanzi, AC Fonseca, AY Elgendy - Stroke, 2021 - Am Heart Assoc
Multiple randomized clinical trials have demonstrated the benefit of patent foramen ovale
closure over medical therapy alone for patients who have had a stroke that has been …

Long-term follow-up after closure of patent foramen ovale in patients with cryptogenic embolism

J Wintzer-Wehekind, A Alperi, C Houde, JM Côté… - Journal of the American …, 2019 - jacc.org
Background Patent foramen ovale (PFO) closure is the gold standard for treating patients
with cryptogenic stroke and PFO. However, scarce data exist on the long-term outcomes …

[HTML][HTML] New-onset atrial fibrillation following percutaneous patent foramen ovale closure: a systematic review and meta-analysis of randomised trials

AY Elgendy, IY Elgendy, MK Mojadidi… - …, 2019 - eurointervention.pcronline.com
Methods Electronic databases were searched for randomised trials that compared
percutaneous PFO closure versus control for patients with cryptogenic stroke or migraine …